Murphy & Mullick Capital Management Corp Bristol Myers Squibb CO Transaction History
Murphy & Mullick Capital Management Corp
- $109 Billion
- Q4 2024
A detailed history of Murphy & Mullick Capital Management Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Murphy & Mullick Capital Management Corp holds 5,436 shares of BMY stock, worth $304,089. This represents 0.28% of its overall portfolio holdings.
Number of Shares
5,436Holding current value
$304,089% of portfolio
0.28%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,671Shares Held
1.47BCall Options Held
31.9MPut Options Held
35.3M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.37 Billion0.44% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.2 Billion0.2% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.37 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...